viernes, 28 de febrero de 2020

A very special episode of the Readout LOUD

The Readout
Damian Garde & Meghana Keshavan

A very special episode of the Readout LOUD

Is the market over-reacting to the coronavirus? Why do so many clinical trials go unfilled? And how do you pronounce “Martin Shkreli?”
We discuss all that and more on this, the 100th episode of “The Readout LOUD,” STAT’s biotech podcast. First, we delve into the stock market’s frenetic reaction to the novel coronavirus outbreak and how it’s affecting biotech companies. Then, we talk to Todd Mercer, a patient from Michigan with a rare type of cancer, about how difficult it can be to enroll in a clinical trial.

Later, we revisit the first episode of this podcast to update the big stories of yesteryear and discover just how embarrassed we should be. Finally, we field questions from listeners, covering genetically engineered pets, putting a dollar value on human life, and the importance of gossip.

No hay comentarios: